{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:05:13Z","timestamp":1779217513234,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104727","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:30:44Z","timestamp":1757608244000},"page":"104727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiotherapy for laryngeal cancers: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Audrey","family":"Maury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Lapeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nolwenn","family":"Delaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-4487","authenticated-orcid":false,"given":"Julian","family":"Biau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2025.104727_bib0290","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1278-3218(10)70007-X","article-title":"Cancer de l\u2019hypopharynx et du larynx\u00a0: proposition de s\u00e9lection et d\u00e9limitation des volumes cibles microscopiques p\u00e9ritumoraux (aires ganglionnaires exclues)","volume":"14","author":"Lapeyre","year":"2010","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0295","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10103-018-2695-2","article-title":"Efficacy of laser surgery versus radiotherapy for treatment of glottic carcinoma: a systematic review and meta-analysis","volume":"34","author":"Ding","year":"2019","journal-title":"Lasers Med Sci"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hed.20500","article-title":"Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: Costs, local control, survival, quality of life, and voice quality","volume":"29","author":"Goor","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2025.104727_bib0305","series-title":"StatPearls","article-title":"Glottic Cancer","author":"Williamson","year":"2025"},{"issue":"7","key":"10.1016\/j.canrad.2025.104727_bib0310","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/lary.31273","article-title":"Outcomes of supracricoid partial laryngectomy performed in the United States: a systematic review","volume":"134","author":"Saturno","year":"2024","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.canrad.2025.104727_bib0315","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s00405-023-07904-2","article-title":"Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma","volume":"280","author":"de\u00a0Ridder","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOO.0000000000000438","article-title":"Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature","volume":"26","author":"Hendriksma","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"Suppl. 1","key":"10.1016\/j.canrad.2025.104727_bib0325","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1177\/0145561320928198","article-title":"Laser microsurgery versus radiotherapy versus open partial laryngectomy for T2 laryngeal carcinoma: a systematic review of oncological outcomes","volume":"100","author":"Campo","year":"2021","journal-title":"Ear Nose Throat J"},{"issue":"6","key":"10.1016\/j.canrad.2025.104727_bib0330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0022215122001682","article-title":"Long-term functional outcomes in tumour stage T2 glottic carcinoma after radiotherapy","volume":"137","author":"Hendriksma","year":"2023","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0335","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy","volume":"78","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104727_bib0340","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3389\/fonc.2019.00932","article-title":"Influencing factors on radiotherapy outcome in stage I-II glottic larynx cancer\u2014a multicenter study","volume":"9","author":"Elicin","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104727_bib0345","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv368","article-title":"Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil,\u00b1docetaxel for larynx preservation","volume":"108","author":"Janoray","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.canrad.2025.104727_bib0350","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.canrad.2025.104727_bib0355","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.canrad.2025.104727_bib0360","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.canrad.2025.104727_bib0365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00106-022-01177-7","article-title":"[Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients]","volume":"70","author":"Dyckhoff","year":"2022","journal-title":"HNO"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (Gortec 99-02): an open-label phase 3 randomised trial","volume":"13","author":"Bourhis","year":"2012","journal-title":"Lancet Oncol"},{"issue":"31","key":"10.1016\/j.canrad.2025.104727_bib0375","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1200\/JCO.2017.76.2591","article-title":"Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the Gortec 2007-02 phase III randomized trial","volume":"36","author":"Geoffrois","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104727_bib0380","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijrobp.2022.03.033","article-title":"Nodal Metastasis count and oncologic outcomes in head and neck cancer: a secondary analysis of NRG\/RTOG 9501, NRG\/RTOG 0234, and EORTC 22931","volume":"113","author":"Lu","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.canrad.2025.104727_bib0385","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0390","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0395","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/odi.15123","article-title":"Parameters to assess the necessity of adjuvant therapy for early-stage oral squamous cell carcinoma","volume":"31","author":"Lu","year":"2025","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0400","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(01)01690-X","article-title":"Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer","volume":"51","author":"Ang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0405","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02841860802372272","article-title":"IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult","volume":"48","author":"Ho","year":"2009","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(03)00405-X","article-title":"Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0415","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0420","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0425","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ijrobp.2017.03.050","article-title":"Patterns of care for patients with early-stage glottic cancer undergoing definitive radiation therapy: a National Cancer database analysis","volume":"98","author":"Stokes","year":"2017","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0430","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0360-3016(98)00547-1","article-title":"Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients","volume":"43","author":"Marshak","year":"1999","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0440","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ijrobp.2023.06.251","article-title":"Long-term follow-up of a randomized controlled trial on accelerated radiation therapy versus standard fractionated radiation therapy for early glottic cancer (JCOG0701A3)","volume":"117","author":"Kodaira","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0445","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2017.02.218","article-title":"Final report of a prospective randomized trial to evaluate the dose\u2013response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer","volume":"98","author":"Rosenthal","year":"2017","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0450","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0360-3016(02)03938-X","article-title":"Results of radiotherapy for T2N0 glottic carcinoma: does the \u201c2\u201d stand for twice-daily treatment?","volume":"55","author":"Garden","year":"2003","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0455","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2005.05.018","article-title":"Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease","volume":"63","author":"Cellai","year":"2005","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104727_bib0460","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0196-0709(97)90058-2","article-title":"Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for \u201cearly\u201d glottic carcinoma classified as T1-T2N0 invading the anterior commissure","volume":"18","author":"Laccourreye","year":"1997","journal-title":"Am J Otolaryngol"},{"issue":"7","key":"10.1016\/j.canrad.2025.104727_bib0465","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hed.21262","article-title":"Role of radiotherapy in early glottic carcinoma","volume":"32","author":"Smee","year":"2010","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0470","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1748-717X-6-53","article-title":"Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons","volume":"6","author":"Tong","year":"2011","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.prro.2011.03.003","article-title":"Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients","volume":"1","author":"Walker","year":"2011","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104727_bib0480","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13014-014-0321-4","article-title":"GTV delineation in supraglottic laryngeal carcinoma: interobserver agreement of CT versus CT-MR delineation","volume":"10","author":"Jager","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104727_bib0485","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.oraloncology.2018.10.034","article-title":"Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma","volume":"87","author":"Gr\u00e9goire","year":"2018","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0490","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0495","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2008.11.059","article-title":"Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer","volume":"75","author":"Salama","year":"2009","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104727_bib0500","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canrad.2005.05.003","article-title":"\u00c9tablissement des volumes cibles anatomocliniques (clinical target volume) pour les cancers laryng\u00e9s en fonction de la localisation de d\u00e9part et des modalit\u00e9s d\u2019extension","volume":"9","author":"Bidault","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104727_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104727_bib0510","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11547-024-01929-1","article-title":"Nodal assessment and extranodal extension in head and neck squamous cell cancer: insights from computed tomography and magnetic resonance imaging","volume":"130","author":"Maggialetti","year":"2025","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0515","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0520","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.canrad.2025.104727_bib0525","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hed.1144","article-title":"Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect","volume":"23","author":"Mukherji","year":"2001","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.canrad.2025.104727_bib0530","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3109\/00016489.2014.920109","article-title":"Management of cervical lymph nodes for cN0 advanced glottic laryngeal carcinoma and its long-term results","volume":"134","author":"Ma","year":"2014","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/019459989310800102","article-title":"Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus","volume":"108","author":"Weber","year":"1993","journal-title":"Otolaryngol Neck Surg"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0540","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2018.04.020","article-title":"Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation","volume":"128","author":"Van Den Bosch","year":"2018","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104727_bib0545","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1016\/j.ijrobp.2010.12.015","article-title":"Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer","volume":"81","author":"Bradley","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104727_bib0550","doi-asserted-by":"crossref","first-page":"109790","DOI":"10.1016\/j.radonc.2023.109790","article-title":"Cine MRI-based analysis of intrafractional motion in radiation treatment planning of head and neck cancer patients","volume":"186","author":"Weiss","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104727_bib0555","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the postoperative neck","volume":"79","author":"Gr\u00e9goire","year":"2006","journal-title":"Radiother Oncol"},{"issue":"5\u20136","key":"10.1016\/j.canrad.2025.104727_bib0560","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.canrad.2014.06.013","article-title":"D\u00e9lin\u00e9ation des ad\u00e9nopathies et aires ganglionnaires pour les cancers de la sph\u00e8re ORL","volume":"18","author":"Lpeyre","year":"2014","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2025.104727_bib0565","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1148\/radiology.175.3.2188292","article-title":"A surgeon looks at cervical lymph nodes","volume":"175","author":"Johnson","year":"1990","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.canrad.2025.104727_bib0570","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jso.21018","article-title":"Current status of FDG-PET for head and neck cancer","volume":"97","author":"Wong","year":"2008","journal-title":"J Surg Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182500143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182500143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:55:55Z","timestamp":1765526155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182500143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S127832182500143X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104727","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for laryngeal cancers: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104727"}}